Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder.
ACS Medicinal Chemistry Letters January 9, 2025 DOI: 10.1021/acsmedchemlett.4c00581 (opens in new tab) via PubMed
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Citations | 7 |
| Key finding | Novel 3-pyrrolidineindole derivatives act as serotonergic psychedelic agents with potential to treat depression, post-traumatic stress disorder, and psychosis. |
Abstract
Provided herein are novel 3-pyrrolidineindole derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis and mental illnesses such as depression and post-traumatic stress disorder, and processes for preparing such compounds.